Skip to content

Scorpio NRG (eNeRGize) Cruciate Retaining (CR) Post-market International Outcome Study

Scorpio NRG Prospective, Open-label, Post-market International Multicentre Outcome Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524730
Acronym
Scorpio NRG
Enrollment
205
Registered
2015-08-17
Start date
2009-05-18
Completion date
2020-02-10
Last updated
2024-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Knee

Brief summary

The purpose of this study is to collect basic function, radiographic and patient satisfaction data for observation and analysis.

Detailed description

Evaluation of the effect of the component design on functional performance by comparing postoperative Knee Society Scores (KSS) with preoperative. Evaluate post-operative radiographic findings. Evaluate the effect of component design on patient activity by comparing postoperative Lower Extremity Activity Scale (LEAS) with preoperative. Evaluate patient satisfaction using Short-Form-36 Health Survey (SF-36). Evaluate quality of life using Knee Injury and Osteoarthritis Outcome Score (KOOS) and EuroQuol-5 dimension patient questionaire (EQ-5D).

Interventions

DEVICEPrimary total knee replacement (Scorpio NRG CR Total Knee System)

Scorpio NRG CR Total Knee System

Sponsors

Stryker Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patient is able to understand the meaning of the study and is willing to sign the Ethic Commission approved, study specific Informed Patient Consent Form. 2. The subject is a male or non-pregnant female between 40 and 75 years of age. 3. The subject requires a primary total knee replacement. 4. Patients with osteoarthritis or posttraumatic arthritis (no rheumatoid arthritis) 5. The subject has intact collateral ligaments. 6. The subject is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation. 7. The subject is capable of understanding the patient scores in the national language.

Exclusion criteria

1. The subject is morbidly obese, defined as Body Mass Index (BMI) of \> 40. 2. The subject has a history of total or unicompartmental reconstruction of the affected joint. 3. The subject will be operated bilaterally. 4. Patients who had a Total Hip Arthroplasty (THA) on contralateral and/or ipsilateral side within the last year that is considered to have an unsatisfactory outcome (Patients with contralateral and/or ipsilateral THA \> 1 year ago with good outcome can be included in the study). 5. Patients who had a Total Knee Arthroplasty (TKA) on contralateral side within the last 6 months that is considered to have an unsatisfactory outcome. (Patients with contralateral TKA \> 6 months ago with good outcome can be included in the study). 6. Patients who will need lower limb joint replacement for another joint within one year. 7. The subject has had a high tibial osteotomy or femoral osteotomy. 8. The subject has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device. 9. The subject has a systemic or metabolic disorder leading to progressive bone deterioration. 10. The subject is immunologically suppressed or receiving steroids in excess of normal physiological requirements. 11. The subject's bone stock in compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis. 12. The subject has had a knee fusion to the affected joint. 13. The subject has an active or suspected latent infection in or about the knee joint. 14. Proven or suspected hypersensitivity to one or more than one of the device materials (see Appendix 10 table of chemical composition). 15. Female patients planning a pregnancy during the course of the study. 16. The subject is a prisoner. 17. severe deformities: varus/valgus deformity \>10° (mech. axis), bowed femur \> 20 degree, flexion contracture \>10°

Design outcomes

Primary

MeasureTime frameDescription
Survival Rate7 year follow-upAssess survival (absence of revision) at 7 year follow-up

Secondary

MeasureTime frameDescription
Investigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pre-operative, 3 months, 1, 3, 5 and optional 7 yearsThe Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as excellent, good, fair, or poor, a higher value represents a better outcome.
Investigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient QuestionnairePre-operative, 3 months,1, 3, 5 and optional 7 yearsThe LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.
Investigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative, 3 months,1, 3, 5 and optional 7 yearsThe SF-36 is a 36-item patient completed questionnaire to measure general health and well-being. It includes physical and mental status component sub scores (physical function, physical role functioning, body pain, general health, vitality, social functioning, emotional role, mental health); each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.
Investigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Pre-operative,1, 5 and optional 7 yearsKOOS consists of 5 subscales: Pain, other symptoms, function in daily living , function in sport and recreation and knee related quality of life (QOL). The previous week is the time period considered when answering the questions. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms).
Investigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Pre-operative, 3 months,1, 3, 5 and optional 7 yearsThe EuroQol-5 Dimension (EQ-5D) is a subject-completed questionnaire designed to assess subject health state values. The EQ-5D consists of 2 areas; EQ-5D descriptive system and the visual analogue scale (VAS). The EQ-5D descriptive system comprises the following five dimensions: mobility self care, usual activities, pain/comfort and anxiety/depression. Each dimension has 3 levels indicating no problems, some problems or extreme problems. The index values on a scale between -1 (low) and 1 (high) are showing the average health status according to the 5 dimensions: A low score shows worse health and a high score shows better health. With the EQ VAS the respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).

Countries

Austria, Germany, Netherlands, United Kingdom

Participant flow

Recruitment details

205 participants who agreed to participate in the study following completion of the informed consent process were enrolled into the study

Participants by arm

ArmCount
Scorpio NRG CR Total Knee System
Primary total knee replacement Primary total knee replacement (Scorpio NRG CR Total Knee System): Scorpio NRG CR Total Knee System
205
Total205

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event8
Overall StudyDeath10
Overall StudyLost to Follow-up5
Overall StudyProtocol Violation1
Overall StudySubjects received Scorpio NRG PS (Posterior Stabilizing)4
Overall StudyWithdrawal by Subject18

Baseline characteristics

CharacteristicScorpio NRG CR Total Knee System
Age, Continuous65.53 years
STANDARD_DEVIATION 6.5
Indication
Osteoarthritis
200 participants
Indication
Post-traumatic Arthritis
4 participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Europe
205 participants
Sex: Female, Male
Female
132 Participants
Sex: Female, Male
Male
72 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
10 / 205
other
Total, other adverse events
15 / 205
serious
Total, serious adverse events
88 / 205

Outcome results

Primary

Survival Rate

Assess survival (absence of revision) at 7 year follow-up

Time frame: 7 year follow-up

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Scorpio NRG CR Total Knee SystemSurvival RateTibial Tray Revision1 Participants
Scorpio NRG CR Total Knee SystemSurvival RateTotal Knee Arthroplasty Revision4 Participants
Scorpio NRG CR Total Knee SystemSurvival RateFemoral Component Revision2 Participants
Scorpio NRG CR Total Knee SystemSurvival RateInlay Revision1 Participants
Scorpio NRG CR Total Knee SystemSurvival RateNo Revision189 Participants
Secondary

Investigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).

The EuroQol-5 Dimension (EQ-5D) is a subject-completed questionnaire designed to assess subject health state values. The EQ-5D consists of 2 areas; EQ-5D descriptive system and the visual analogue scale (VAS). The EQ-5D descriptive system comprises the following five dimensions: mobility self care, usual activities, pain/comfort and anxiety/depression. Each dimension has 3 levels indicating no problems, some problems or extreme problems. The index values on a scale between -1 (low) and 1 (high) are showing the average health status according to the 5 dimensions: A low score shows worse health and a high score shows better health. With the EQ VAS the respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).

Time frame: Pre-operative, 3 months,1, 3, 5 and optional 7 years

Population: Numbers analyzed represent evaluable cases.

ArmMeasureGroupValue (MEAN)Dispersion
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Pre-operative visual analogue scale (VAS)70.97 units on a scaleStandard Deviation 16.75
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).VAS at 3 months76.96 units on a scaleStandard Deviation 13.92
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).VAS at 1 year77.41 units on a scaleStandard Deviation 14.4
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).VAS at 3 years75.09 units on a scaleStandard Deviation 14.11
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).VAS at 5 years76.84 units on a scaleStandard Deviation 13.23
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).VAS at 7 years77.03 units on a scaleStandard Deviation 14.77
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Pre-operative descriptive EQ-5D0.55 units on a scaleStandard Deviation 0.26
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Descriptive EQ-5D at 3 months0.77 units on a scaleStandard Deviation 0.17
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Descriptive EQ-5D at 1 year0.84 units on a scaleStandard Deviation 0.17
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Descriptive EQ-5D at 3 years0.83 units on a scaleStandard Deviation 0.19
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Descriptive EQ-5D at 5 years0.82 units on a scaleStandard Deviation 0.2
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Descriptive EQ-5D at 7 years0.83 units on a scaleStandard Deviation 0.19
Secondary

Investigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.

KOOS consists of 5 subscales: Pain, other symptoms, function in daily living , function in sport and recreation and knee related quality of life (QOL). The previous week is the time period considered when answering the questions. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms).

Time frame: Pre-operative,1, 5 and optional 7 years

Population: Numbers analyzed represent evaluable cases. The KOOS was collected pre-operatively and at 1, 5 and 7 years only.

ArmMeasureGroupValue (MEAN)Dispersion
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.QoL at 7 years65.54 units on a scaleStandard Deviation 21.81
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Symptoms pre-operative49.91 units on a scaleStandard Deviation 18.55
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Symptoms at 1 year79.58 units on a scaleStandard Deviation 15.73
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Symptoms at 5 years83.38 units on a scaleStandard Deviation 16.1
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Symptoms at 7 years85.83 units on a scaleStandard Deviation 15.46
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Pain pre-operative41.28 units on a scaleStandard Deviation 17.82
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Pain at 1 year82.9 units on a scaleStandard Deviation 19.14
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Pain at 5 years84.36 units on a scaleStandard Deviation 19.38
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Pain at 7 years86.99 units on a scaleStandard Deviation 17.74
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Function, sports and recreation activities pre-operative14.15 units on a scaleStandard Deviation 16.26
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Function, sports and recreation activities at 1 year47.89 units on a scaleStandard Deviation 29.08
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Function, sports and recreation activities at 5 years48.71 units on a scaleStandard Deviation 31.05
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Function, sports and recreation activities at 7 years52.79 units on a scaleStandard Deviation 33.45
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Quality of life (QoL) pre-operative24.36 units on a scaleStandard Deviation 14.86
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.QoL at 1 year66.19 units on a scaleStandard Deviation 24.11
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.QoL at 5 years66.78 units on a scaleStandard Deviation 23.41
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Function, daily living pre-operative46.59 units on a scaleStandard Deviation 18.2
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Function, daily living at 1 year82.7 units on a scaleStandard Deviation 17.35
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Function, daily living at 5 years83.47 units on a scaleStandard Deviation 18.46
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire.Function, daily living at 7 years84.24 units on a scaleStandard Deviation 19.23
Secondary

Investigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)

The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as excellent, good, fair, or poor, a higher value represents a better outcome.

Time frame: Pre-operative, 3 months, 1, 3, 5 and optional 7 years

Population: Numbers analyzed represent evaluable cases

ArmMeasureGroupValue (MEAN)Dispersion
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pre-operative pain motion score57.84 units on a scaleStandard Deviation 13.34
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pain motion score at 3 months78.71 units on a scaleStandard Deviation 12.36
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pain motion score at 1 year83.27 units on a scaleStandard Deviation 10.15
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pain motion score at 3 years83.85 units on a scaleStandard Deviation 11.42
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pain motion score at 5 years84.73 units on a scaleStandard Deviation 11.57
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pain motion score at 7 years84.20 units on a scaleStandard Deviation 10.33
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pre-operative function score61.54 units on a scaleStandard Deviation 17.78
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Function score at 3 months78.05 units on a scaleStandard Deviation 16.95
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Function score at 1 year87.99 units on a scaleStandard Deviation 15.68
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Function score at 3 years85.00 units on a scaleStandard Deviation 19.34
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Function score at 5 years83.75 units on a scaleStandard Deviation 19.75
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Function score at 7 years83.51 units on a scaleStandard Deviation 21.43
Secondary

Investigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient Questionnaire

The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.

Time frame: Pre-operative, 3 months,1, 3, 5 and optional 7 years

Population: Numbers analyzed represent evaluable cases.

ArmMeasureGroupValue (MEAN)Dispersion
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient Questionnairepre-operative activity level8.61 units on a scaleStandard Deviation 2.51
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient QuestionnaireActivity level at 3 months9.43 units on a scaleStandard Deviation 2.81
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient QuestionnaireActivity level at 1 year11.11 units on a scaleStandard Deviation 3.06
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient QuestionnaireActivity level at 3 years10.68 units on a scaleStandard Deviation 3
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient QuestionnaireActivity level at 5 years10.38 units on a scaleStandard Deviation 3.09
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient QuestionnaireActivity level at 7 years10.75 units on a scaleStandard Deviation 3.2
Secondary

Investigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)

The SF-36 is a 36-item patient completed questionnaire to measure general health and well-being. It includes physical and mental status component sub scores (physical function, physical role functioning, body pain, general health, vitality, social functioning, emotional role, mental health); each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

Time frame: Pre-operative, 3 months,1, 3, 5 and optional 7 years

Population: Numbers analyzed represent evaluable cases.

ArmMeasureGroupValue (MEAN)Dispersion
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative physical function30.62 units on a scaleStandard Deviation 7.91
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical function at 3 months40.2 units on a scaleStandard Deviation 8.86
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical function at 1 year44.67 units on a scaleStandard Deviation 8.6
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical function at 3 years43.97 units on a scaleStandard Deviation 9.8
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical function at 5 years42.41 units on a scaleStandard Deviation 10.8
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical function at 7 years43.07 units on a scaleStandard Deviation 10.71
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative physical role functioning34.48 units on a scaleStandard Deviation 9.19
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical role functioning at 3 months39.04 units on a scaleStandard Deviation 9.34
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical role functioning at 1 year45.11 units on a scaleStandard Deviation 9.77
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical role functioning at 3 years44.0 units on a scaleStandard Deviation 9.77
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical role functioning at 5 years43.26 units on a scaleStandard Deviation 10.75
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Physical role functioning at 7 years43.65 units on a scaleStandard Deviation 10.56
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative body pain42.24 units on a scaleStandard Deviation 3.23
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Body pain at 3 months40.69 units on a scaleStandard Deviation 3.52
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Body pain at 1 year39.72 units on a scaleStandard Deviation 3.28
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Body pain at 3 years39.47 units on a scaleStandard Deviation 3.17
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Body pain at 5 years39.48 units on a scaleStandard Deviation 3.74
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Body pain at 7 years39.35 units on a scaleStandard Deviation 3.3
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative general health49.2 units on a scaleStandard Deviation 8.15
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)General health at 3 months51.48 units on a scaleStandard Deviation 7.57
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)General health at 1 year51.6 units on a scaleStandard Deviation 8.28
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)General health at 3 years49.9 units on a scaleStandard Deviation 8.38
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)General health at 5 years48.95 units on a scaleStandard Deviation 9.02
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)General health at 7 years48.11 units on a scaleStandard Deviation 8.82
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative vitality49.94 units on a scaleStandard Deviation 8.61
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Vitality at 3 months52.73 units on a scaleStandard Deviation 8.93
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Vitality at 1 year55.71 units on a scaleStandard Deviation 9.4
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Vitality at 3 years54.61 units on a scaleStandard Deviation 9.46
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Vitality at 5 years54.42 units on a scaleStandard Deviation 8.56
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Vitality at 7 years54.52 units on a scaleStandard Deviation 9.38
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative social functioning44.67 units on a scaleStandard Deviation 10.12
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Social functioning at 3 months49.17 units on a scaleStandard Deviation 8.91
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Social functioning at 1 year51.16 units on a scaleStandard Deviation 8.54
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Social functioning at 3 years51.27 units on a scaleStandard Deviation 8.26
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Social functioning at 5 years50.83 units on a scaleStandard Deviation 7.96
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Social functioning at 7 years49.97 units on a scaleStandard Deviation 8.98
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative emotional role43.41 units on a scaleStandard Deviation 12.92
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Emotional role at 3 months46.65 units on a scaleStandard Deviation 11.65
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Emotional role at 1 year47.81 units on a scaleStandard Deviation 11.1
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Emotional role at 3 years46.83 units on a scaleStandard Deviation 10.81
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Emotional role at 5 years47.47 units on a scaleStandard Deviation 11.4
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Emotional role at 7 years46.0 units on a scaleStandard Deviation 11.78
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Pre-operative mental health50.23 units on a scaleStandard Deviation 9.4
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Mental health at 3 months52.6 units on a scaleStandard Deviation 9.86
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Mental health at 1 year53.39 units on a scaleStandard Deviation 9.96
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Mental health at 3 years53.06 units on a scaleStandard Deviation 8.8
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Mental health at 5 years53.52 units on a scaleStandard Deviation 8.63
Scorpio NRG CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form - 36 Health Survey (SF-36)Mental health at 7 years52.5 units on a scaleStandard Deviation 9.36

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026